NewMediaWire distributes press releases on behalf of hundreds of publicly traded companies, as well as private corporations, non-profits and other public sector organizations. Founded and staffed by industry veterans, we offer a full complement of services including specialized delivery to financial sites and posting of photos and multimedia content. In addition, NewMediawire offers international and specialized services such as IR websites and industry specific distribution.
RSS Feed for NewMediaWireNovember 11, 2025 — By Meg Flippin, Benzinga DETROIT, MICHIGAN - November 11, 2025 (NEWMEDIAWIRE) - When it comes to monitoring independent seniors, much of the focus is reactionary, whether it's watching for falls, prolonged inactivity or when vital signs drop below critical thresholds. But what if the care could be preventive?
November 11, 2025 — SAN DIEGO, CA - November 11, 2025 (NEWMEDIAWIRE) - Quantumzyme Corp. (OTCQB: QTZM), a global leader in computational enzyme engineering and digital biocatalysis, today announced the expansion of its proprietary AI-powered enzyme design platform to target additional high-volume Active Pharmaceutical Ingredients (APIs) beyond ibuprofen.
November 11, 2025 — NEW YORK, NY - November 11, 2025 (NEWMEDIAWIRE) - PhillComm Global, the world’s premier PR firm for emerging industries, today announced it has been appointed the agency of record for futurist Matt Maher and his firm, M7 Innovations. The partnership marks a powerful alignment between two forces shaping the future of innovation, technology, and storytelling.
November 11, 2025 — LANCASTER, PA - November 11, 2025 (NEWMEDIAWIRE) - BitFrontier Capital Holdings, Inc. (OTCID: BFCH), doing business as UNLOCKD Inc.
November 11, 2025 — NEW YORK, NY - November 10, 2025 (NEWMEDIAWIRE) - As businesses grapple with rising marketing costs and increasing demand for faster campaign deployment, Search Atlas CEO and CTO Manick Bhan emerges as a leading voice in the revolutionary “Vibe SEO” movement. Manick declares that “businesses adopting Vibe SEO methodologies could reduce the time it takes to deploy marketing efforts, allowing teams to push out changes quicker and easier than ever before,” according to his Vibe SEO presentation during the Search Atlas Live 2025 event in New York City on September 26, 2025.
November 10, 2025 — SOFIA, Bulgaria and MUNICH - November 10, 2025 (NEWMEDIAWIRE) - Shelly Group SE (Ticker SLYG / ISIN: BG1100003166) ("Shelly Group"), a provider of IoT and smart building solutions based in Sofia, Bulgaria, invites investors and analysts to an earnings webcast/call with the Management Board members on 13 November 2025, 09. 00 CET (10.
November 10, 2025 — SEVENUM, The Netherlands - November 10, 2025 (NEWMEDIAWIRE) - Redcare Pharmacy’s Supervisory Board has designated Hendrik Krampe as member of the Managing Board and Chief Financial Officer, effective 1 December 2025. He succeeds Jasper Eenhorst, who stepped down to pursue new professional opportunities.
November 10, 2025 — FRANKFURT/MAIN, Germany - November 10, 2025 (NEWMEDIAWIRE) - The Payments Group Holding (PGH), a holding company based in Frankfurt am Main that was founded in 2012 and renamed in August 2024, is updating the Group’s preliminary financial targets for the next three years. For this purpose, PGH assumes that the pending closing of the acquisition of 75% of The Payments Group companies (TPG), agreed in August 2024, will take place in 2025 and that they will therefore be fully consolidated into the enlarged Group from 2026 onwards.
November 10, 2025 — FORT LAUDERDALE, FL - November 10, 2025 (NEWMEDIAWIRE) - Splash Beverage Group, Inc. (NYSE American: SBEV) (“Splash” or the “Company”), a portfolio company of emerging beverage brands, today announced that its Founder, Chief Executive Officer, and Chairman of the Board, Robert Nistico, has resigned from his roles as CEO and Chairman.
November 10, 2025 — Research Highlights: After 24 months, 34% of veterans who have heart and blood vessel disease and high cholesterol in a quality improvement program that included health care coaches and other resources had improved cholesterol levels to below 70 mg/dL. The quality-improvement program increased the number of military veterans with better LDL (“bad” cholesterol) levels of less than 70mg/dL, and more than a third of those ages 75 and older achieved their lower cholesterol goal.
November 10, 2025 — LOS ANGELES, CA - November 10, 2025 (NEWMEDIAWIRE) - NRx Pharmaceuticals (NASDAQ: NRXP), announced that its subsidiary, HOPE Therapeutics(TM), has initiated patient care using the Ampa “one day” (ONE-D) protocol for treatment-resistant depression - the first deployment of its kind in Florida and among the first nationwide. The Ampa device combines a single day of transcranial magnetic stimulation (TMS) with physician-prescribed D-cycloserine and lisdexamfetamine, which in peer-reviewed studies have shown response rates of 87% and remission rates of 72% in nonrandomized trials.
November 10, 2025 — LOS ANGELES, CA - November 10, 2025 (NEWMEDIAWIRE) - D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a global leader in quantum computing systems, software and services, and Davidson Technologies, Inc.
November 10, 2025 — DALLAS, TX - November 10, 2025 (NEWMEDIAWIRE) - Despite major advances in care, nearly half of U. S.
November 10, 2025 — Research Highlights: Among 150 adults who had been recently hospitalized for heart failure, those who received deliveries of prepared meals or fresh produce along with dietary counseling reported improved quality of life compared to adults who only received dietary guidance without food delivery. There were no differences in the number of hospital readmissions or emergency department visits for heart failure between participants who received food delivery compared to those who did not.
November 10, 2025 — Research Highlights: The cholesterol-lowering medication alirocumab, a PCSK9 inhibitor, along with a statin, lowered LDL cholesterol levels more than 50% in patients after a heart transplant, compared to those taking a placebo plus statin, according to the results of a new clinical trial. Researchers found alirocumab did not reduce the risk of developing cardiac allograft vasculopathy, a progressive coronary artery disease that occurs after a heart transplant.
November 10, 2025 — Premier Technology Investment Forum to Connect 100+ Companies With Institutional Investors November 18-19 in New York The ROTH Technology Conference, a B2i Digital Featured Conference, Will be Showcased to B2i Digital’s Community of More Than 1. 4 Million Investors NEW YORK, NY - November 10, 2025 (NEWMEDIAWIRE) - B2i Digital, Inc.
November 10, 2025 — Research Highlights: Among patients with heart failure and reduced ejection fraction (HFrEF), those taking a “polypill” combination of three medications typically prescribed for heart failure, once daily for six months, had improved heart function and symptoms, better quality of life, fewer hospitalizations and greater medication adherence in comparison to those who took the same medications as separate pills. This is the first study to evaluate a polypill strategy in people with HFrEF, focused on improving medication adherence and simplifying treatment.
November 10, 2025 — Research Highlights: Chest pain may still be angina even when the main heart arteries look clear. Using cardiac stress MRI (a heart scan that measures blood flow with magnetic resonance imaging), testing uncovered small vessel problems in about half of participants in a study of people who had prior coronary angiography that indicated no obstructive coronary artery disease.
November 10, 2025 — Research Highlights: Two P2Y12 inhibitors often used interchangeably, ticagrelor and prasugrel (antiplatelet medications prescribed to prevent the formation of blood clots), had different impacts on outcomes in patients with Type 1 or Type 2 diabetes who had undergone stent placement, a procedure done to keep an artery open, and free of clots or a blockage. While both medications help prevent platelets from clumping together and forming a clot in a stent, the study showed they may not offer the same level of benefits in the patients studied.
November 10, 2025 — Positioning GeoVax as a Diversified, Made-in-America Vaccine Leader with Global Market Relevance ATLANTA, GA - November 10, 2025 (NEWMEDIAWIRE) - GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing multi-antigen vaccines and immunotherapies for infectious diseases and cancer, today recognized World Immunization Day, a global observance highlighting the lifesaving power of vaccines and the urgent need to address rising concerns about vaccine confidence.